Weekly Roundups,Biology,News

Weekly News Round-up – 16/4/21

3 years ago By Charlotte Di Salvo

In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public funding for the Oxford/AstraZeneca vaccine. 

RESEARCH REVEALS 97% OF FUNDING FOR OXFORD COVID-19 WAS TAXPAYERS AND CHARITABLE SUPPORT – According to a recent research paper, the development of the Oxford/AstraZeneca COVID-19 vaccine was funded at least 97% by the public or charitable trusts including the Wellcome Trust. The paper in question details how “less than 2% of the identified funding came from private industry”. Despite waiting to be peer reviewed, the research team have declared that their data supported the truth that “public investment and international collaboration gave us the Covid-19 vaccines”.

J&J URGED TO CLARIFY CANCELLED DEPLOYMENT OF COVID-19 VACCINE IN EUROPE- Despite aiming to deliver 55 million doses to the EU by the end of June, J&J have temporarily suspended COVID-19 vaccine rollout in europe. The European Commission is now seeking “urgent clarification” from J&J. The suspension of J&J’s vaccine in Europe comes after blood clot concerns in the US, which the European Medicines Agency are currently reviewing. 

TWIST BIOSCIENCE PARTNERSHIP HOPES TO ACCELERATE ANTIBODY-BASED DRUG DISCOVERY – Biopharma Twist Bioscience partnered with Pure Biologics to optimise the discovery of antibody candidates for immunoncological targets. The biopharma division of Twist Bioscience has granted access for Pure Biologics to “select synthetic antibody phage display libraries”. The collaboration is hoping to support the potential of highly selective, potent antibodies in future cancer treatment.

R&D
Promising findings in identification of genetic site in susceptibility of breast cancer 

Manufacturing
UK drug discovery company licenses agreement with Sanofi to develop and commercialise inflammatory drug 

Clinical
Immunotherapy combination therapy shows potential for cancer treatment in clinical trial

That’s all for now. See you next week!

Charlotte Di Salvo, Junior Medical Writer
Proventa International

More news

Navigating the Complex World of Global Regulatory Affairs in Oncology

In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...

9 months ago
Weekly Roundups,Biology,News

Navigating the Complex World of Global Regulatory Affairs in Oncology

In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...

9 months ago

Overcoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials

In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...

9 months ago
Weekly Roundups,Biology,News

Overcoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials

In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...

9 months ago

Embracing a Patient-Centric Approach in Oncology Trials

In the realm of healthcare and medical research, the term "patient-centric" has gained significant traction in recent years. This shift in focus towards prioritizing patients' needs and preferences is not only transforming the healthcare industry but is also making waves...

9 months ago
Weekly Roundups,Biology,News

Embracing a Patient-Centric Approach in Oncology Trials

In the realm of healthcare and medical research, the term "patient-centric" has gained significant traction in recent years. This shift in focus towards prioritizing patients' needs and preferences is not only transforming the healthcare industry but is also making waves...

9 months ago